Nutrien (NYSE:NTR - Get Free Report) had its target price decreased by analysts at Freedom Broker from $78.00 to $76.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a "hold" rating on the stock. Freedom Broker's price objective indicates a potential upside of 6.21% from the stock's previous close.
A number of other analysts have also weighed in on the company. Mizuho lowered their target price on Nutrien from $77.00 to $75.00 and set a "neutral" rating for the company in a research note on Tuesday, July 14th. UBS Group upped their price target on shares of Nutrien from $59.00 to $62.00 and gave the stock a "sell" rating in a research report on Tuesday, October 27th. KeyCorp initiated coverage on shares of Nutrien in a report on Thursday, September 10th. They set a "sector weight" rating and a $73.00 price objective on the stock. Canadian Imperial Bank of Commerce reissued an "outperform" rating on shares of Nutrien in a report on Monday, August 10th. Finally, Jefferies Financial Group restated a "hold" rating and issued a $71.00 price objective on shares of Nutrien in a research report on Monday, October 12th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $79.14.
Read Our Latest Research Report on Nutrien
Nutrien Price Performance
Shares of NYSE NTR traded down $0.62 during mid-day trading on Wednesday, hitting $71.55. 570,518 shares of the stock were exchanged, compared to its average volume of 2,984,739. Nutrien has a twelve month low of $54.52 and a twelve month high of $85.36. The stock's fifty day simple moving average is $72.76 and its two-hundred day simple moving average is $71.15. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.89 and a current ratio of 1.41. The company has a market cap of $34.01 billion, a P/E ratio of 15.60, a PEG ratio of 0.80 and a beta of 0.67.
Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported $0.61 EPS for the quarter, missing analysts' consensus estimates of $0.74 by ($0.13). The business had revenue of $5.69 billion for the quarter, compared to the consensus estimate of $5.66 billion. Nutrien had a return on equity of 8.00% and a net margin of 7.78%. The firm's revenue was up .9% on a year-over-year basis. During the same quarter last year, the company earned $0.97 earnings per share. As a group, analysts forecast that Nutrien will post 4.53 EPS for the current fiscal year.
Hedge Funds Weigh In On Nutrien
A number of hedge funds and other institutional investors have recently bought and sold shares of NTR. Wellington Management Group LLP bought a new position in shares of Nutrien in the 2nd quarter worth $654,081,000. Deutsche Bank AG bought a new position in Nutrien during the second quarter worth about $588,720,000. The Manufacturers Life Insurance Company acquired a new position in shares of Nutrien during the 2nd quarter worth about $375,178,000. Canada Pension Plan Investment Board acquired a new position in shares of Nutrien during the 2nd quarter worth about $359,318,000. Finally, BlackRock Inc. bought a new stake in shares of Nutrien in the 2nd quarter valued at about $220,942,000. 63.10% of the stock is owned by institutional investors.
Nutrien Company Profile
(
Get Free Report)
Nutrien Ltd. is a Canadian agricultural inputs and services company headquartered in Saskatoon, Saskatchewan. Formed in 2018 through the merger of Agrium and Potash Corporation of Saskatchewan, it serves farmers and other customers through fertilizer production and agricultural retail operations. The company produces potash, nitrogen and phosphate fertilizers, which are used to support crop growth. It also sells crop protection products and seeds, and provides growers with agronomic advice and other services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.